Screener / SEC EDGAR /CIK 0000070318 /10-K filed Feb 17, 2026, compared with Feb 18, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Hospitals

Tenet Healthcare Corp THC

Compare with peers Embed

THC among the 162 companies we cover

Where it stands · the better end on the right. The band holds the middle half; the line is the median.

All 162
Sales growth
+4.8%+20.2%
+3.1%125th of 155 · median +10.5%
Net margin
-4.1%15.3%
13.1%52nd of 154 · median 6.8%
Return on equity
-5.2%18.5%
53.3%8th of 144 · median 9.2%
Free cash flow margin
2.3%19.2%
15.0%53rd of 145 · median 10.0%
Debt / equity (less is better)
1.160.42
2.43100th of 108 · median 0.69

THC and 9 peers, year by year

The 9 Health care companies closest to THC in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

Choose the peers

Health care companies (up to 9):

Each company's latest fiscal year
CompanyYearRevenueSales growthGross marginOperating marginNet marginFCF marginReturn on equityDebt / equity
THC Tenet Healthcare Corp FY2025 $21.3B+3.1%-16.5%6.6%11.9%33.3%3.12
BDX Becton Dickinson FY2025 $21.8B+8.2%-11.8%7.7%12.2%6.6%0.76
GEHC GE HealthCare FY2025 $20.6B+4.8%40.0%13.4%10.1%7.3%20.1%1.01
BSX Boston Scientific FY2025 $20.1B+19.9%69.0%18.0%14.4%18.2%12.0%0.47
DHR Danaher Corporation FY2025 $24.6B+2.9%59.1%19.1%14.7%21.4%6.9%0.35
UHS Universal Health Services FY2025 $17.4B+9.7%-11.5%8.6%4.9%20.5%0.66
SYK Stryker Corporation FY2025 $25.1B+11.2%64.0%19.5%12.9%17.1%14.5%0.66
IQV IQVIA FY2025 $16.3B+5.9%-13.4%8.3%12.6%20.9%2.42
TEVA Teva Pharmaceutical Industries Ltd FY2025 $17.3B+4.3%51.8%12.5%8.2%6.7%17.8%2.12
REGN Regeneron Pharmaceuticals FY2025 $14.3B+1.0%-24.9%31.4%28.4%14.4%0.06

Each company, year by year

Bars: revenue, each company on its own scale. Line: net margin, on one scale for all. FY2016 to FY2025 · 10-K XBRL

THCTenet Healthcare Corp
FY2016 revenue $21.1BFY2017 revenue $20.6BFY2018 revenue $18.3BFY2019 revenue $18.5BFY2020 revenue $17.6BFY2021 revenue $19.5BFY2022 revenue $19.2BFY2023 revenue $20.6BFY2024 revenue $20.7BFY2025 revenue $21.3B FY2016 net margin −0.9%FY2017 net margin −3.4%FY2018 net margin 0.6%FY2019 net margin −1.2%FY2020 net margin 2.3%FY2021 net margin 4.7%FY2022 net margin 2.1%FY2023 net margin 3.0%FY2024 net margin 15.5%FY2025 net margin 6.6% FY2016FY2025
Revenue$21.3B Growth+3.1% Net margin6.6%
BDXBecton Dickinson
FY2016 revenue $12.5BFY2017 revenue $12.1BFY2018 revenue $16.0BFY2019 revenue $17.3BFY2020 revenue $16.1BFY2021 revenue $19.1BFY2022 revenue $18.9BFY2023 revenue $19.4BFY2024 revenue $20.2BFY2025 revenue $21.8B FY2016 net margin 7.8%FY2017 net margin 9.1%FY2018 net margin 1.9%FY2019 net margin 7.1%FY2020 net margin 5.4%FY2021 net margin 10.9%FY2022 net margin 9.4%FY2023 net margin 7.7%FY2024 net margin 8.4%FY2025 net margin 7.7% FY2016FY2025
Revenue$21.8B Growth+8.2% Net margin7.7%
GEHCGE HealthCare
FY2021 revenue $17.6BFY2022 revenue $18.3BFY2023 revenue $19.6BFY2024 revenue $19.7BFY2025 revenue $20.6B FY2021 net margin 12.8%FY2022 net margin 10.4%FY2023 net margin 8.0%FY2024 net margin 10.1%FY2025 net margin 10.1% FY2016FY2025
Revenue$20.6B Growth+4.8% Net margin10.1%
BSXBoston Scientific
FY2016 revenue $9.1BFY2017 revenue $9.0BFY2018 revenue $9.8BFY2019 revenue $10.7BFY2020 revenue $9.9BFY2021 revenue $11.9BFY2022 revenue $12.7BFY2023 revenue $14.2BFY2024 revenue $16.7BFY2025 revenue $20.1B FY2016 net margin 3.8%FY2017 net margin 1.1%FY2018 net margin 17.0%FY2019 net margin 43.8%FY2020 net margin −1.2%FY2021 net margin 8.3%FY2022 net margin 5.1%FY2023 net margin 11.0%FY2024 net margin 11.1%FY2025 net margin 14.4% FY2016FY2025
Revenue$20.1B Growth+19.9% Net margin14.4%
DHRDanaher Corporation
FY2016 revenue $16.9BFY2017 revenue $15.5BFY2018 revenue $17.0BFY2019 revenue $17.9BFY2020 revenue $22.3BFY2021 revenue $24.8BFY2022 revenue $26.6BFY2023 revenue $23.9BFY2024 revenue $23.9BFY2025 revenue $24.6B FY2016 net margin 15.1%FY2017 net margin 16.1%FY2018 net margin 15.5%FY2019 net margin 16.8%FY2020 net margin 16.4%FY2021 net margin 25.9%FY2022 net margin 27.1%FY2023 net margin 19.9%FY2024 net margin 16.3%FY2025 net margin 14.7% FY2016FY2025
Revenue$24.6B Growth+2.9% Net margin14.7%
UHSUniversal Health Services
FY2016 revenue $9.8BFY2017 revenue $10.4BFY2018 revenue $10.8BFY2019 revenue $11.4BFY2020 revenue $11.6BFY2021 revenue $12.6BFY2022 revenue $13.4BFY2023 revenue $14.3BFY2024 revenue $15.8BFY2025 revenue $17.4B FY2016 net margin 7.2%FY2017 net margin 7.2%FY2018 net margin 7.2%FY2019 net margin 7.2%FY2020 net margin 8.2%FY2021 net margin 7.8%FY2022 net margin 5.0%FY2023 net margin 5.0%FY2024 net margin 7.2%FY2025 net margin 8.6% FY2016FY2025
Revenue$17.4B Growth+9.7% Net margin8.6%
SYKStryker Corporation
FY2016 revenue $11.3BFY2017 revenue $12.4BFY2018 revenue $13.6BFY2019 revenue $14.9BFY2020 revenue $14.4BFY2021 revenue $17.1BFY2022 revenue $18.4BFY2023 revenue $20.5BFY2024 revenue $22.6BFY2025 revenue $25.1B FY2016 net margin 14.5%FY2017 net margin 8.2%FY2018 net margin 26.1%FY2019 net margin 14.0%FY2020 net margin 11.1%FY2021 net margin 11.7%FY2022 net margin 12.8%FY2023 net margin 15.4%FY2024 net margin 13.2%FY2025 net margin 12.9% FY2016FY2025
Revenue$25.1B Growth+11.2% Net margin12.9%
IQVIQVIA
FY2016 revenue $6.9BFY2017 revenue $9.7BFY2018 revenue $10.4BFY2019 revenue $11.1BFY2020 revenue $11.4BFY2021 revenue $13.9BFY2022 revenue $14.4BFY2023 revenue $15.0BFY2024 revenue $15.4BFY2025 revenue $16.3B FY2016 net margin 1.0%FY2017 net margin 13.1%FY2018 net margin 2.5%FY2019 net margin 1.7%FY2020 net margin 2.5%FY2021 net margin 7.0%FY2022 net margin 7.6%FY2023 net margin 9.1%FY2024 net margin 8.9%FY2025 net margin 8.3% FY2016FY2025
Revenue$16.3B Growth+5.9% Net margin8.3%
TEVATeva Pharmaceutical Industries Ltd
FY2016 revenue $21.9BFY2017 revenue $22.4BFY2018 revenue $18.3BFY2019 revenue $16.9BFY2020 revenue $16.7BFY2021 revenue $15.9BFY2022 revenue $14.9BFY2023 revenue $15.8BFY2024 revenue $16.5BFY2025 revenue $17.3B FY2016 net margin 1.5%FY2017 net margin −72.7%FY2018 net margin −11.8%FY2019 net margin −5.9%FY2020 net margin −24.0%FY2021 net margin 2.6%FY2022 net margin −16.4%FY2023 net margin −3.5%FY2024 net margin −9.9%FY2025 net margin 8.2% FY2016FY2025
Revenue$17.3B Growth+4.3% Net margin8.2%
REGNRegeneron Pharmaceuticals
FY2016 revenue $4.9BFY2017 revenue $5.9BFY2018 revenue $5.1BFY2019 revenue $6.6BFY2020 revenue $8.5BFY2021 revenue $16.1BFY2022 revenue $12.2BFY2023 revenue $13.1BFY2024 revenue $14.2BFY2025 revenue $14.3B FY2016 net margin 18.4%FY2017 net margin 20.4%FY2018 net margin 47.5%FY2019 net margin 32.3%FY2020 net margin 41.3%FY2021 net margin 50.2%FY2022 net margin 35.6%FY2023 net margin 30.1%FY2024 net margin 31.1%FY2025 net margin 31.4% FY2016FY2025
Revenue$14.3B Growth+1.0% Net margin31.4%

Who rewrote the most

Share of the words changed in Risk Factors and in MD&A, latest 10-K against the one before

Risk FactorsMD&AEach company's latest 10-K, so the dates differ. A company that rewrote much may have reorganized the text.

Revenue, FY2016 to FY2025

Revenue as reported in the 10-K.

100 200 FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 BDX: $12.5B, $12.1B, $16.0B, $17.3B, $16.1B, $19.1B, $18.9B, $19.4B, $20.2B, $21.8B BDX GEHC: -, -, -, -, -, $17.6B, $18.3B, $19.6B, $19.7B, $20.6B GEHC BSX: $9.1B, $9.0B, $9.8B, $10.7B, $9.9B, $11.9B, $12.7B, $14.2B, $16.7B, $20.1B BSX DHR: $16.9B, $15.5B, $17.0B, $17.9B, $22.3B, $24.8B, $26.6B, $23.9B, $23.9B, $24.6B DHR UHS: $9.8B, $10.4B, $10.8B, $11.4B, $11.6B, $12.6B, $13.4B, $14.3B, $15.8B, $17.4B UHS SYK: $11.3B, $12.4B, $13.6B, $14.9B, $14.4B, $17.1B, $18.4B, $20.5B, $22.6B, $25.1B SYK IQV: $6.9B, $9.7B, $10.4B, $11.1B, $11.4B, $13.9B, $14.4B, $15.0B, $15.4B, $16.3B IQV TEVA: $21.9B, $22.4B, $18.3B, $16.9B, $16.7B, $15.9B, $14.9B, $15.8B, $16.5B, $17.3B TEVA REGN: $4.9B, $5.9B, $5.1B, $6.6B, $8.5B, $16.1B, $12.2B, $13.1B, $14.2B, $14.3B REGN THC: $21.1B, $20.6B, $18.3B, $18.5B, $17.6B, $19.5B, $19.2B, $20.6B, $20.7B, $21.3B THC
THC is the bold green line; each peer has its own colour and dash, named at the line's end. Each company's first year in the window is 100, on a log scale: a line twice as high has doubled. A gap is a year with no number. A ring marks where a line starts: GEHC has no earlier 10-K here. DHR, REGN: the line is cut where a later 10-K restates the year before (a spin-off or a merger), so the two years are not the same company.

Sales growth, FY2016 to FY2025

Revenue against the fiscal year before.

−24.3% +89.1% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 BDX: +21.4%, −3.1%, +32.2%, +8.2%, −1.0%, +19.0%, −1.4%, +2.7%, +4.2%, +8.2% BDX GEHC: -, -, -, -, -, -, +4.3%, +6.6%, +0.6%, +4.8% GEHC BSX: +12.2%, +7.9%, +8.6%, +9.3%, −7.7%, +19.9%, +6.7%, +12.3%, +17.6%, +19.9% BSX DHR: +17.0%, +8.6%, +9.9%, +5.1%, +24.4%, +32.2%, +7.4%, −10.3%, −0.1%, +2.9% DHR UHS: +8.0%, +6.6%, +3.5%, +5.6%, +1.6%, +9.4%, +6.0%, +6.6%, +10.8%, +9.7% UHS SYK: +13.9%, +9.9%, +9.3%, +9.4%, −3.6%, +19.2%, +7.8%, +11.1%, +10.2%, +11.2% SYK IQV: +19.9%, +42.4%, +7.3%, +6.5%, +2.4%, +22.1%, +3.9%, +4.0%, +2.8%, +5.9% IQV TEVA: +11.5%, +2.2%, −16.4%, −7.6%, −1.4%, −4.7%, −6.0%, +6.2%, +4.4%, +4.3% TEVA REGN: +18.4%, +20.8%, +14.3%, +27.4%, +29.6%, +89.1%, −24.3%, +7.8%, +8.3%, +1.0% REGN THC: -, −2.2%, −4.5%, +0.9%, −4.5%, +10.5%, −1.6%, +7.2%, +0.5%, +3.1% THC
THC is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −24.3% to +89.1%. A gap is a year with no number. A ring marks where a line starts: THC, GEHC have no earlier 10-K here.

Gross margin, FY2016 to FY2025

Gross profit / revenue.

39.1% 71.4% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 BDX: 48.0%, 49.1%, 45.5%, 47.9%, 47.1%, -, -, -, -, - BDX GEHC: -, -, -, -, -, 40.8%, 39.1%, 40.5%, 41.7%, 40.0% GEHC BSX: 65.7%, 71.3%, 71.4%, 71.0%, 65.0%, 68.8%, 68.8%, 69.5%, 68.6%, 69.0% BSX DHR: 55.3%, 55.2%, 55.8%, 55.7%, 56.0%, 61.4%, 60.8%, 58.7%, 59.5%, 59.1% DHR SYK: 66.3%, 65.7%, 65.7%, 65.1%, 63.1%, 64.1%, 62.8%, 63.7%, 63.9%, 64.0% SYK TEVA: 53.2%, 47.4%, 45.4%, 44.6%, 46.4%, 47.8%, 46.7%, 48.2%, 48.7%, 51.8% TEVA
THC is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 39.1% to 71.4%. A gap is a year with no number. A ring marks where a line starts: GEHC has no earlier 10-K here.
CompanyFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
THC Dec ----------
BDX Sep 48.0%49.1%45.5%47.9%47.1%-----
GEHC Dec -----40.8%39.1%40.5%41.7%40.0%
BSX Dec 65.7%71.3%71.4%71.0%65.0%68.8%68.8%69.5%68.6%69.0%
DHR Dec 55.3%55.2%55.8%55.7%56.0%61.4%60.8%58.7%59.5%59.1%
UHS Dec ----------
SYK Dec 66.3%65.7%65.7%65.1%63.1%64.1%62.8%63.7%63.9%64.0%
IQV Dec ----------
TEVA Dec 53.2%47.4%45.4%44.6%46.4%47.8%46.7%48.2%48.7%51.8%
REGN Dec ----------
Peer median55.3%55.2%55.8%55.7%56.0%61.4%60.8%58.7%59.5%59.1%

Operating margin, FY2016 to FY2025

Operating income / revenue.

−78.1% 55.7% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 BDX: 11.5%, 12.6%, 9.4%, 10.2%, 5.7%, 11.8%, 12.1%, 10.9%, 11.9%, 11.8% BDX GEHC: -, -, -, -, -, 15.9%, 13.8%, 12.5%, 13.3%, 13.4% GEHC BSX: 4.9%, 14.2%, 15.3%, 14.1%, −0.8%, 10.1%, 13.0%, 16.5%, 15.5%, 18.0% BSX DHR: 16.2%, 16.6%, 17.9%, 18.3%, 19.0%, 25.7%, 28.3%, 21.8%, 20.4%, 19.1% DHR UHS: 13.1%, 12.3%, 10.9%, 10.7%, 11.8%, 10.8%, 7.5%, 8.2%, 10.6%, 11.5% UHS SYK: 19.2%, 18.5%, 18.7%, 18.2%, 15.5%, 15.1%, 15.4%, 19.0%, 16.3%, 19.5% SYK IQV: 8.4%, 6.8%, 7.1%, 7.0%, 6.4%, 10.0%, 12.5%, 13.2%, 14.3%, 13.4% IQV TEVA: 9.8%, −78.1%, −9.0%, −2.6%, −21.4%, 10.8%, −14.7%, 2.7%, −1.8%, 12.5% TEVA REGN: 27.4%, 35.4%, 49.3%, 33.7%, 42.1%, 55.7%, 38.9%, 30.9%, 28.1%, 24.9% REGN THC: 5.9%, 5.4%, 8.9%, 8.3%, 11.3%, 14.7%, 12.2%, 12.2%, 28.8%, 16.5% THC
THC is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −78.1% to 55.7%. A gap is a year with no number. A ring marks where a line starts: GEHC has no earlier 10-K here.

Net margin, FY2016 to FY2025

Net income / revenue.

−72.7% 50.2% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 BDX: 7.8%, 9.1%, 1.9%, 7.1%, 5.4%, 10.9%, 9.4%, 7.7%, 8.4%, 7.7% BDX GEHC: -, -, -, -, -, 12.8%, 10.4%, 8.0%, 10.1%, 10.1% GEHC BSX: 3.8%, 1.1%, 17.0%, 43.8%, −1.2%, 8.3%, 5.1%, 11.0%, 11.1%, 14.4% BSX DHR: 15.1%, 16.1%, 15.5%, 16.8%, 16.4%, 25.9%, 27.1%, 19.9%, 16.3%, 14.7% DHR UHS: 7.2%, 7.2%, 7.2%, 7.2%, 8.2%, 7.8%, 5.0%, 5.0%, 7.2%, 8.6% UHS SYK: 14.5%, 8.2%, 26.1%, 14.0%, 11.1%, 11.7%, 12.8%, 15.4%, 13.2%, 12.9% SYK IQV: 1.0%, 13.1%, 2.5%, 1.7%, 2.5%, 7.0%, 7.6%, 9.1%, 8.9%, 8.3% IQV TEVA: 1.5%, −72.7%, −11.8%, −5.9%, −24.0%, 2.6%, −16.4%, −3.5%, −9.9%, 8.2% TEVA REGN: 18.4%, 20.4%, 47.5%, 32.3%, 41.3%, 50.2%, 35.6%, 30.1%, 31.1%, 31.4% REGN THC: −0.9%, −3.4%, 0.6%, −1.2%, 2.3%, 4.7%, 2.1%, 3.0%, 15.5%, 6.6% THC
THC is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −72.7% to 50.2%. A gap is a year with no number. A ring marks where a line starts: GEHC has no earlier 10-K here.

Free cash flow, FY2016 to FY2025

Cash from operations minus capital spending.

−$317.0M $7.4B FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 BDX: $1.9B, $1.8B, $2.0B, $2.4B, $2.8B, $3.5B, $1.5B, $2.1B, $3.1B, $2.7B BDX GEHC: -, -, -, -, -, $1.4B, $1.8B, $1.7B, $1.6B, $1.5B GEHC BSX: $806.0M, $1.1B, −$6.0M, $1.4B, $1.1B, $1.3B, $938.0M, $1.8B, $2.6B, $3.7B BSX DHR: $2.9B, $2.9B, $3.4B, $3.3B, $5.4B, $7.1B, $7.4B, $5.8B, $5.3B, $5.3B DHR UHS: $813.9M, $690.1M, $609.8M, $804.4M, $1.6B, $28.0M, $262.0M, $524.7M, $1.1B, $849.2M UHS SYK: $1.4B, $961.0M, $2.0B, $1.5B, $2.8B, $2.7B, $2.0B, $3.1B, $3.5B, $4.3B SYK IQV: $696.0M, $601.0M, $795.0M, $835.0M, $1.3B, $2.3B, $1.6B, $1.5B, $2.1B, $2.1B IQV TEVA: $3.0B, $1.4B, $1.8B, $223.0M, $638.0M, $236.0M, $1.0B, $842.0M, $749.0M, $1.1B TEVA REGN: $974.0M, $1.0B, $1.8B, $2.0B, $2.0B, $6.5B, $4.4B, $3.9B, $3.7B, $4.1B REGN THC: −$317.0M, $493.0M, $432.0M, $563.0M, $2.9B, $910.0M, $321.0M, $1.6B, $1.1B, $2.5B THC
THC is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −$317.0M to $7.4B. A gap is a year with no number. A ring marks where a line starts: GEHC has no earlier 10-K here.

FCF margin, FY2016 to FY2025

Free cash flow / revenue.

−1.5% 40.6% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 BDX: 14.9%, 15.1%, 12.3%, 13.7%, 17.2%, 18.0%, 7.9%, 10.9%, 15.5%, 12.2% BDX GEHC: -, -, -, -, -, 7.7%, 9.9%, 8.8%, 7.9%, 7.3% GEHC BSX: 8.9%, 12.2%, −0.1%, 12.8%, 11.4%, 11.1%, 7.4%, 12.6%, 15.8%, 18.2% BSX DHR: 17.4%, 18.7%, 20.2%, 18.5%, 24.3%, 28.7%, 27.8%, 24.2%, 22.2%, 21.4% DHR UHS: 8.3%, 6.6%, 5.7%, 7.1%, 14.1%, 0.2%, 2.0%, 3.7%, 7.1%, 4.9% UHS SYK: 12.6%, 7.7%, 15.0%, 10.4%, 19.4%, 16.0%, 11.0%, 15.3%, 15.4%, 17.1% SYK IQV: 10.1%, 6.2%, 7.6%, 7.5%, 11.8%, 16.6%, 11.0%, 10.0%, 13.7%, 12.6% IQV TEVA: 13.6%, 6.0%, 9.8%, 1.3%, 3.8%, 1.5%, 7.0%, 5.3%, 4.5%, 6.7% TEVA REGN: 20.0%, 17.6%, 35.2%, 30.5%, 23.6%, 40.6%, 36.3%, 29.5%, 25.8%, 28.4% REGN THC: −1.5%, 2.4%, 2.4%, 3.0%, 16.3%, 4.7%, 1.7%, 7.9%, 5.4%, 11.9% THC
THC is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −1.5% to 40.6%. A gap is a year with no number. A ring marks where a line starts: GEHC has no earlier 10-K here.

Return on equity, FY2016 to FY2025

Net income / shareholders' equity at the year end.

−93.7% 88.9% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 BDX: 12.8%, 8.5%, 1.5%, 5.8%, 3.7%, 8.8%, 7.0%, 5.8%, 6.6%, 6.6% BDX GEHC: -, -, -, -, -, 13.5%, 20.5%, 22.0%, 23.6%, 20.1% GEHC BSX: 5.2%, 1.5%, 19.1%, 33.9%, −0.8%, 5.9%, 3.7%, 8.1%, 8.5%, 12.0% BSX DHR: 11.1%, 9.5%, 9.4%, 9.9%, 9.2%, 14.2%, 14.4%, 8.9%, 7.9%, 6.9% DHR UHS: 15.5%, 15.1%, 14.5%, 14.8%, 14.9%, 16.3%, 11.4%, 11.7%, 17.1%, 20.5% UHS SYK: 17.2%, 10.2%, 30.3%, 16.3%, 12.2%, 13.4%, 14.2%, 17.0%, 14.5%, 14.5% SYK IQV: 0.8%, 16.0%, 3.9%, 3.2%, 4.6%, 16.0%, 18.9%, 22.2%, 22.6%, 20.9% IQV TEVA: 1.0%, −93.7%, −14.6%, −7.2%, −39.8%, 4.1%, −31.3%, −7.4%, −30.5%, 17.8% TEVA REGN: 20.1%, 19.5%, 27.9%, 19.1%, 31.9%, 43.0%, 19.1%, 15.2%, 15.0%, 14.4% REGN THC: −46.0%, n/m, n/m, n/m, n/m, 88.9%, 36.0%, 38.0%, 76.7%, 33.3% THC
THC is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −93.7% to 88.9%. A gap is a year with no number. A ring marks where a line starts: GEHC has no earlier 10-K here.

Debt / equity, FY2016 to FY2025

Total debt / shareholders' equity at the year end.

0.00 15.22 FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 BDX: 1.51, 1.46, 1.02, 0.92, 0.75, 0.74, 0.64, 0.62, 0.78, 0.76 BDX GEHC: -, -, -, -, -, -, 0.88, 1.46, 1.24, 1.01 GEHC BSX: 0.80, 0.80, 0.81, 0.72, 0.60, 0.55, 0.51, 0.47, 0.49, 0.47 BSX DHR: 0.65, 0.41, 0.35, 0.72, 0.53, 0.49, 0.40, 0.38, 0.33, 0.35 DHR UHS: 0.91, 0.81, 0.74, 0.72, 0.61, 0.69, 0.81, 0.80, 0.68, 0.66 UHS SYK: 0.72, 0.66, 0.72, 0.80, 1.01, 0.84, 0.71, 0.59, 0.59, 0.66 SYK IQV: 0.84, 1.28, 1.64, 1.94, 2.09, 2.01, 2.21, 2.24, 2.30, 2.42 IQV TEVA: 0.98, 1.66, 1.97, 1.93, 2.59, 2.24, 2.72, 2.64, 3.31, 2.12 TEVA REGN: -, -, -, 0.00, 0.18, 0.11, 0.09, 0.08, 0.07, 0.06 REGN THC: n/m, n/m, n/m, n/m, n/m, 15.22, 13.20, 9.33, 3.16, 3.12 THC
THC is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 0.00 to 15.22. A gap is a year with no number. A ring marks where a line starts: THC, GEHC, REGN have no earlier 10-K here.

EPS (diluted), FY2016 to FY2025

Diluted earnings per share, on today's share count after splits.

−$16.26 $71.97 FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 BDX: $4.49, $4.60, $0.60, $3.94, $2.71, $6.85, $5.88, $4.94, $5.86, $5.82 BDX GEHC: -, -, -, -, -, $4.95, $4.22, $3.03, $4.34, $4.55 GEHC BSX: $0.25, $0.08, $1.19, $3.33, −$0.08, $0.69, $0.45, $1.07, $1.25, $1.94 BSX DHR: $3.65, $3.53, $3.74, $4.05, $4.89, $8.61, $9.66, $6.38, $5.29, $5.05 DHR UHS: $7.14, $7.81, $8.31, $9.13, $10.99, $11.82, $9.14, $10.23, $16.82, $23.10 UHS SYK: $4.35, $2.68, $9.34, $5.48, $4.20, $5.21, $6.17, $8.25, $7.76, $8.40 SYK IQV: $0.47, $5.74, $1.24, $0.96, $1.43, $4.95, $5.72, $7.29, $7.49, $7.84 IQV TEVA: $0.07, −$16.26, −$2.35, −$0.91, −$3.64, $0.38, −$2.20, −$0.50, −$1.45, $1.21 TEVA REGN: $7.70, $10.34, $21.29, $18.46, $30.52, $71.97, $38.22, $34.77, $38.34, $41.48 REGN THC: −$1.93, −$7.00, $1.00, −$2.08, $3.75, $8.42, $3.79, $5.71, $32.70, $15.49 THC
THC is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −$16.26 to $71.97. A gap is a year with no number. A ring marks where a line starts: GEHC has no earlier 10-K here.

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out THC and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more

Sources

Each company's 10-K, from SEC's XBRL company facts. Every number links to its filing in the Inline XBRL viewer.

Also

Financials: THC's own statements, year by year. Compare: the whole peer group on one page.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/THC/export.csv") into a cell.

Next:Industry numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.